| 
																	
																		 
																		 Cryptococcus neoformans
 
																		 
																		
																	 
																		 
																		
																	 
																			
																					
	"Cryptococcus neoformans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
 
	
	
		
			
			
				A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans.
    
			 
				
				
					
						| Descriptor ID | D003455 |  
						| MeSH Number(s) | B01.300.381.258.366 B01.300.930.316.366 |  
						| Concept/Terms |  |  
				Below are MeSH descriptors whose meaning is more general than "Cryptococcus neoformans". 
				Below are MeSH descriptors whose meaning is more specific than "Cryptococcus neoformans". 
	
	
		
			
			
					
				This graph shows the total number of publications written about "Cryptococcus neoformans" by people in this website by year, and whether "Cryptococcus neoformans" was a major or minor topic of these publications.  
					  To see the data from this visualization as text, click here. 
		            | Year | Major Topic | Minor Topic | Total | 
|---|
 | 2002 | 1 | 0 | 1 |  | 2003 | 1 | 0 | 1 |  | 2004 | 1 | 0 | 1 |  | 2005 | 1 | 0 | 1 |  | 2010 | 2 | 0 | 2 |  | 2011 | 1 | 0 | 1 |  | 2018 | 3 | 0 | 3 |  | 2019 | 1 | 0 | 1 |  | 2020 | 1 | 0 | 1 |  | 2022 | 1 | 0 | 1 |  | 2023 | 1 | 0 | 1 |  | 2024 | 1 | 0 | 1 | 
 
                    To return to the timeline, click here. 
				Below are the most recent publications written about "Cryptococcus neoformans" by people in Profiles. 		
					
								
								Kim L, Ferraz C, Corbisiero MF, Gorvetzian S, Franco-Paredes C, Krsak M, Shapiro L, Thompson GR, Chastain DB, Tuells J, Henao-Mart?nez AF. Glucocorticoids as a risk factor for infection and adverse outcomes in non-HIV and non-transplant patients with cryptococcal meningitis. Mycoses. 2024 Mar; 67(3):e13709.
								Alanazi AH, Chastain DB, Rudraraju M, Parvathagiri V, Shan S, Lin X, Henao-Mart?nez AF, Franco-Paredes C, Narayanan SP, Somanath PR. A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitis. Eur J Pharmacol. 2023 Dec 05; 960:176177.
								Hoy MJ, Park E, Lee H, Lim WY, Cole DC, DeBouver ND, Bobay BG, Pierce PG, Fox D, Ciofani M, Juvvadi PR, Steinbach W, Hong J, Heitman J. Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit In Vivo Therapeutic Efficacy against Cryptococcus. mBio. 2022 06 28; 13(3):e0104922.
								Mann S, Tobolowsky F, Purohit S, Henao-Mart?nez A, Bajrovic V, Ramanan P, Wolfel E, Khazanie P, Barron M, Madinger N, Benamu E. Cryptococcal pericarditis in a heart transplant recipient. Transpl Infect Dis. 2020 Dec; 22(6):e13366.
								Juvvadi PR, Fox D, Bobay BG, Hoy MJ, Gobeil SMC, Venters RA, Chang Z, Lin JJ, Averette AF, Cole DC, Barrington BC, Wheaton JD, Ciofani M, Trzoss M, Li X, Lee SC, Chen YL, Mutz M, Spicer LD, Schumacher MA, Heitman J, Steinbach WJ. Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents. Nat Commun. 2019 09 19; 10(1):4275.
								Twede JV, Peters KM. Primary cutaneous cryptococcosis in an immunocompetent Iraq War veteran. Cutis. 2018 Nov; 102(5):E30-E31.
								Henao-Mart?nez AF, Chastain DB, Franco-Paredes C. Treatment of cryptococcosis in non-HIV immunocompromised patients. Curr Opin Infect Dis. 2018 08; 31(4):278-285.
								Esher SK, Ost KS, Kohlbrenner MA, Pianalto KM, Telzrow CL, Campuzano A, Nichols CB, Munro C, Wormley FL, Alspaugh JA. Defects in intracellular trafficking of fungal cell wall synthases lead to aberrant host immune recognition. PLoS Pathog. 2018 06; 14(6):e1007126.
								Chastain DB, Guarner J, Franco-Paredes C. Cryptococcal antigen negative meningoencephalitis in HIV/AIDS. Diagn Microbiol Infect Dis. 2017 Oct; 89(2):143-145.
								Sionov E, Chang YC, Garraffo HM, Dolan MA, Ghannoum MA, Kwon-Chung KJ. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14a-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole. Antimicrob Agents Chemother. 2012 Mar; 56(3):1162-9. | 
																	
																		
																			
																					People  People who have written about this concept._ 
    
        Similar Concepts   
        People who have written about this concept.
     _ 
    
        Top Journals   
        Top journals in which articles about this concept have been published.
     |